MTOR and acute lymphoblastic leukemia: As shown in Figure 3F, addition of BEZ235 strongly induced cell death in the absence of XBP1, implying that the genetic ablation of Xbp1 or its pharmacological inhibition with MKC‐8866 strongly sensitizes pre‐B ALL cells to dual inhibition of PI3K/mTOR.